New Cytotoxic Drugs in Treatment of Breast Cancer
- 1 January 1990
- journal article
- review article
- Published by Taylor & Francis in Acta Oncologica
- Vol. 29 (3) , 343-347
- https://doi.org/10.3109/02841869009090012
Abstract
(1990). New Cytotoxic Drugs in Treatment of Breast Cancer. Acta Oncologica: Vol. 29, No. 3, pp. 343-347. doi: 10.3109/02841869009090012Keywords
This publication has 17 references indexed in Scilit:
- Oral Idarubicin in the Treatment of Advanced Breast CancerActa Oncologica, 1989
- A prospective randomized phase III trial comparing combination chemotherapy with cyclophosphamide, fluorouracil, and either doxorubicin or epirubicin. French Epirubicin Study Group.Journal of Clinical Oncology, 1988
- Weekly Low-Dose Doxorubicin as Second Line Therapy in Advanced Breast CancerActa Oncologica, 1988
- A phase II study of oral weekly 4-demethoxydaunorubicin in advanced breast cancerEuropean Journal of Cancer and Clinical Oncology, 1987
- Phase II Study of Oral 4-Demethoxydaunorubicin in Previously Treated (Except Anthracyclines) Metastatic Breast Cancer PatientsOncology, 1987
- Weekly Adriamycin versus VAC in advanced breast cancer. A randomized trialEuropean Journal of Cancer and Clinical Oncology, 1986
- Carminomycin versus doxorubicin in advanced breast cancer, a randomized phase II study of the E.O.R.T.C. breast cancer cooperative groupEuropean Journal of Cancer and Clinical Oncology, 1986
- Weekly-dose doxorubicin (WDA) in advanced breast cancerRadiotherapy and Oncology, 1986
- Activity of 4-demethoxydaunorubicin by the oral route in advanced breast cancerEuropean Journal of Cancer and Clinical Oncology, 1985
- Cancer of the BreastNew England Journal of Medicine, 1980